Clinical Trial

Clinical trial: Novel approach restores brain cells and function in Parkinson’s patients

Pinterest LinkedIn Tumblr

Scientists have developed an innovative approach to treating Parkinson’s patients—administering a naturally occurring growth factor directly into the brain. The reason? While the research is ongoing, the study’s authors hypothesize that introducing Glial Cell Line-Derived Neurotrophic Factor via robot-assisted, surgically-implanted ports could regenerate dying dopamine neurons. (Journal of Parkinson’s Disease

American Healthcare Journal is healthcare’s No. 1 source for the latest insights, news and analysis. An authoritative, digital-first and editorially independent publication committed to providing decision makers with unparalleled thought leadership and objective, industry-focused information to help them run their businesses in the new era of healthcare.